MTVA ▲ +4.9% - MetaVia Inc.
$MTVA MTVA - MetaVia Announces Statistically Significant Reduction in Uric Acid Levels with DA-1726 in Phase 1 Part 3B Clinical Trial
12-NOV-2026 08:31 AM ET
Share this post
More filings for $MTVA
MTVA ▼ -3.5% - MetaVia Inc.Nov 9, 2026MTVA ▲ +1.7% - MetaVia Inc.Oct 28, 2026MTVA ▲ +5.6% - MetaVia Inc.Oct 13, 2026MTVA ▼ -5.1% - MetaVia Inc.Sep 9, 2026
View full $MTVA filing history →💬 Comments
Loading comments…
Leave a comment